Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle.
about
NERVE: new enhanced reverse vaccinology environmentCorrelation between bioluminescence and bacterial burden in passively protected mice challenged with a recombinant bioluminescent M49 group A streptococcus Strain.Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis.Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cellsA novel human IgA monoclonal antibody protects against tuberculosis.CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection.Histopathological Study of the Lungs of Mice Receiving Human Secretory IgA and Challenged with Mycobacterium tuberculosisThe role of B cells and humoral immunity in Mycobacterium tuberculosis infectionRole of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune responseCharacterization of Francisella tularensis outer membrane proteins.Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens.Passive antibody therapy for infectious diseases.New concepts in antibody-mediated immunity.Factors associated with seroconversion to the major piroplasm surface protein of the bovine haemoparasite Theileria orientalisSpecific Monoclonal Antibody Overcomes the Salmonella enterica Serovar Typhimurium's Adaptive Mechanisms of Intramacrophage Survival and Replication.Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigensEvaluation of Humoral Immunity to Mycobacterium tuberculosis-Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development.The potential of antibody-mediated immunity in the defence against biological weapons.Advances in combating fungal diseases: vaccines on the thresholdA new synthesis for antibody-mediated immunity.Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particlesMycobacterium tuberculosis Zinc Metalloprotease-1 Elicits Tuberculosis-Specific Humoral Immune Response Independent of Mycobacterial Load in Pulmonary and Extra-Pulmonary Tuberculosis Patients.Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis.Antibody-mediated immunity against tuberculosis: implications for vaccine developmentCloning, Expression and Purification of Penicillin Binding Protein2a (PBP2a) from Methicillin Resistant Staphylococcus aureus: A Study on Immunoreactivity in Balb/C Mouse.Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform.IgM in microbial infections: taken for granted?Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens.Antibody-Fc receptor interactions in protection against intracellular pathogens.A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis.A role for interleukin-5 in promoting increased immunoglobulin M at the site of disease in leprosy.Repression of Proteases and Hsp90 Chaperone Expression Induced by an Antiretroviral in Virulent Environmental Strains of Cryptococcus neoformans.Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.Exploring the benefits of antibody immune response in HIV-1 infection using a discrete model.Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophagesCD11c expression identifies a population of extrafollicular antigen-specific splenic plasmablasts responsible for CD4 T-independent antibody responses during intracellular bacterial infection.Comment on "Regulation of immunity during visceral Leishmania infection" and further discussions about the role of antibodies in infections with Leishmania.A novel adjuvant, the mixture of alum and naltrexone, augments vaccine-induced immunity against Plasmodium berghei.Efficiency of pH-sensitive fusogenic polymer-modified liposomes as a vaccine carrier.
P2860
Q33250601-20574548-D739-415B-9D15-255044539CACQ33613541-34B20E96-806B-4551-A590-BD64D067A1BCQ33788061-E3F4F0A9-72BE-4D0F-A0D9-891F63711578Q33793546-3FBE773E-8392-4670-B08B-C55BCDEC8E7BQ33800841-D1D465C9-B4E6-4DBB-B55B-998F2254B137Q34177368-6BC9DEEB-611B-481E-B62A-31B86DFB2A18Q34178105-BD76C80F-1136-4F4F-B0F8-E5BEC5D72A94Q35039807-CC917B33-3EFF-4603-BDAA-8A03E1A61BDCQ35164284-B807E5FE-4C11-49FE-A4C8-B401925439F9Q35165024-8315E212-E960-4B3D-A9F9-489E51E4CCC5Q35634834-6C91F838-7332-42F4-95BE-D418E050E376Q35648247-3D0C6A28-230E-4508-B694-5624E0939BBDQ35889582-9105098B-E8DE-4006-A903-2534B2B190B1Q35926507-9148C3C5-30C5-48B7-A409-70992C839935Q35934901-4CA690D6-8839-4E01-B53B-5D32630CD51FQ35960709-662CACAC-B5FC-44FE-BE06-A0B449E52578Q36017488-AF9098BC-FFEB-4BF5-8964-573FA21830B4Q36237421-0B857F9C-BA5D-468B-86F6-B56457EB3F1EQ36273411-E662051E-2B38-4650-8FA8-F4B204E43CB4Q36406460-F9B93A9B-CCE3-484E-9BAA-11FA1E23519BQ36660720-48E90C39-ED44-46C5-95CF-5435E01D1FF5Q36669184-6BAB717D-9018-4CFD-AF3F-A65A34091B60Q36747054-D10014B9-7AA9-4896-BE90-4C90E995FC6EQ36804275-85BFE305-1EB5-4E37-9E5C-8D641D1A450AQ37137882-B2411F22-73B2-4F08-8942-A8C3E7B86151Q37338076-9C6ACFF9-1648-4CF7-9EC7-EEFE6B545070Q37353525-BA6C8116-445B-41DF-AFA0-62E0516DC008Q37524875-C5471115-2FA2-45DB-A46D-044161DF1272Q37683238-7C784850-BE8E-4F26-ACC6-6F50B474955DQ37853942-BA70867E-3AF8-430B-8DDD-E352BFA19B35Q38336530-DE3EA897-9FA0-4BFF-AD0A-F4C3181A03ECQ38506036-9AB47ACD-0684-42A6-9099-0F6A31A1F2F7Q39137674-B9AEB126-2E8E-4F95-B7A1-64199E628DC6Q39330315-FD488DD7-6831-4928-B45B-AE9C7EADF988Q40794254-C79C6082-58AE-4F5C-8208-676490471973Q41437577-FA6482EA-F9AA-494B-8C08-FA279955C836Q42124976-E66D0E68-431C-4027-BC5C-5BF71F47229BQ42429227-66B71B14-6248-4363-AFC4-5B513E5EB482Q47875209-6AB88311-8D4D-47E3-8B8D-EE18076FFCE4Q53119249-E9C4E148-883D-4793-B039-F654BAEEDDF6
P2860
Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antibody-mediated immunity aga ...... al thinking comes full circle.
@ast
Antibody-mediated immunity aga ...... al thinking comes full circle.
@en
type
label
Antibody-mediated immunity aga ...... al thinking comes full circle.
@ast
Antibody-mediated immunity aga ...... al thinking comes full circle.
@en
prefLabel
Antibody-mediated immunity aga ...... al thinking comes full circle.
@ast
Antibody-mediated immunity aga ...... al thinking comes full circle.
@en
P2860
P1476
Antibody-mediated immunity aga ...... al thinking comes full circle.
@en
P2860
P304
P356
10.1128/IAI.71.8.4225-4228.2003
P407
P577
2003-08-01T00:00:00Z